Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. IDEXX Laboratories, Inc.
  6. News
  7. Summary
    IDXX   US45168D1046

IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  05/27 04:00:00 pm EDT
398.61 USD   +3.56%
05/19Goldman Sachs Adjusts IDEXX Laboratories' Price Target to $530 From $615, Maintains Neutral Rating
MT
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IDEXX Laboratories to Launch New Diagnostic Tests for Animal Cancer

01/13/2022 | 07:56am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about IDEXX LABORATORIES, INC.
05/19Goldman Sachs Adjusts IDEXX Laboratories' Price Target to $530 From $615, Maintains Neu..
MT
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K..
AQ
05/05JPMorgan Adjusts Price Target for IDEXX Laboratories to $625 From $725, Maintains Overw..
MT
05/05Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $603 from $732, Keeps Overwe..
MT
05/05BofA Securities Downgrades IDEXX Laboratories to Neutral From Buy, Adjusts Price Target..
MT
05/04IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
05/04Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13..
CI
05/04SECTOR UPDATE : Health Care Stocks Climb Pre-Bell Wednesday
MT
05/04TRANSCRIPT : IDEXX Laboratories, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 447 M - -
Net income 2022 721 M - -
Net Debt 2022 817 M - -
P/E ratio 2022 47,4x
Yield 2022 -
Capitalization 33 486 M 33 486 M -
EV / Sales 2022 9,95x
EV / Sales 2023 8,89x
Nbr of Employees 10 350
Free-Float 77,9%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 398,61 $
Average target price 541,13 $
Spread / Average Target 35,8%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-39.46%33 486
ABBOTT LABORATORIES-17.09%204 317
MEDTRONIC PLC-4.22%131 850
STRYKER CORPORATION-11.56%89 433
BECTON, DICKINSON AND COMPANY2.74%73 108
HOYA CORPORATION-19.93%39 352